Factors associated with increased plasma homocysteine in patients using an amino acid peritoneal dialysis fluid

Nephrology Dialysis Transplantation

Volumn 20, Issue 1, 2005, Pages 161-166

  Yang, Shao Yu ^a,b   Huang, Jenq Wen ^a   Shih, Kai Yao ^a   Hsu, Shih Ping ^b   Chu, Pei Lun ^a   Chu, Tzong Shinn ^a   Wu, Kwan Dun ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Amino acid peritoneal dialysate; Homocysteine; Nutrition; Peritoneal dialysis

Indexed keywords

ALBUMIN; ASPARTATE AMINOTRANSFERASE; CREATININE; FOLIC ACID; GLUCOSE; HOMOCYSTEINE; LEPTIN; METHIONINE; NUTRINEAL; PERITONEAL DIALYSIS FLUID; UREA;

ADULT; AGED; ALBUMIN BLOOD LEVEL; AMINO ACID BLOOD LEVEL; AMINO ACID SUBSTITUTION; APPETITE DISORDER; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY FAT; BODY MASS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE CLEARANCE; DRUG EFFECT; FEMALE; GLUCOSE TRANSPORT; HEMODIALYSIS PATIENT; HUMAN; HYPERHOMOCYSTEINEMIA; HYPOTENSION; INSULIN RESISTANCE; MALE; NAUSEA; NUTRITIONAL PARAMETERS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION; PROTEIN INTAKE; RISK BENEFIT ANALYSIS; UREA BLOOD LEVEL;

ADULT; AMINO ACIDS; DIALYSIS SOLUTIONS; FEMALE; FOLLOW-UP STUDIES; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MALNUTRITION; MIDDLE AGED; PERITONEAL DIALYSIS; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; STATISTICS, NONPARAMETRIC; TAIWAN; TREATMENT OUTCOME;

EID: 13444273613     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh554     Document Type: Article

References (19)

1. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 1996; 7: 198-207
2. Young GA, Kopple JD, Lindholm B et al. Nutritional assessment of continuous ambulatory peritoneal dialysis patients: an international study. Am J Kidney Dis 1991; 17: 462-471
3. Jones M, Hagen T, Boyle CA et al. Treatment of malnutrition with 1.1% amino acid peritoneal dialysis solution: results of a multicenter outpatient study. Am J Kidney Dis 1998; 32: 761-769
4. Misra M, Reaveley DA, Ashworth J, Muller B, Seed M, Brown EA. Six-month prospective cross-over study to determine the effects of 1.1% amino acid dialysate on lipid metabolism in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 1997; 17: 279-286
5. Li FK, Chan LYY, Woo JCY et al. A 3-year, prospective randomized, controlled study on amino acid dialysate in patients on CAPD. Am J Kidney Dis 2003; 42: 173-183
6. Brulez HFH, van Guldener C, Donker AJM, ter Wee PM. The impact of an amino acid-based peritoneal fluid on plasma homocysteine levels, lipid profile and body fat mass. Nephrol Dial Transplant 1999; 14: 154-159
7. Moustapha A, Naso A, Nahlawi M et al. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation 1998; 97: 138-141
8. van Guldener C, Stam F, Stehouwer CDA. Homocysteine metabolism in renal failure. Kidney Int 2001; 59 [Suppl 78]: S234-S237
9. Detsky AS, McLaughlin JR, Baker JP et al. What is subjective global assessment of nutritional status? JPEN-Parenter Enter 1987; 11: 8-13
10. Bates CJ, Pentieva KD, Matthews N, Macdonald A. A simple, sensitive and reproducible assay for pyridoxal 5′-phosphate and 4-pyridoxic acid in human plasma. Clin Chim Acta 1999; 280: 101-111
11. Huang JW, Yen CJ, Pai MF, Wu KD, Tsai TJ, Hsieh BS. Association between serum aspartate transaminase and homocysteine levels in hemodialysis patients. Am J Kidney Dis 2002; 40: 1195-1201
12. Bergström J, Fürst P, Alvestrand A, Lindholm B. Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis. Kidney Int 1993; 44: 1048-1057
13. Cheng SC, Chu TS, Huang KY et al. Association of hypertriglyceridemia and insulin resistance in uremic patients undergoing CAPD. Perit Dial Int 2001; 21: 282-289
14. Metthaws DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419
15. Considine RV, Sinha MK, Heiman ML et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-295
16. Jones MR, Gehr TW, Burkart JM et al. Replacement of amino acid and protein losses with 1.1% amino acid peritoneal dialysis solution. Perit Dial Int 1998; 18: 210-216
17. Suliman ME, Stenvinkel P, Bárány P, Heimbürger O, Anderstam B, Lindholm B. Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hyperhomocysteinemia, malnutrition, inflammation, and diabetes mellitus. Am J Kidney Dis 2003; 41 [Suppl 1]: S89-S95
18. Kalantar-Zadeh K, Block G, Humphreys MH, McAllister CJ, Kopple JD. A low, rather than a high, total plasma homocysteine is an indicator of poor outcome in hemodialysis patients. J Am Soc Nephrol 2004; 15: 442-453
19. Blom HJ, Boers GH, van den Elzen JP, Gahl WA, Tangerman A. Transamination of methionine in humans. Clin Sci 1989; 76: 43-49